Baby formula manufacturer Abbott Laboratories faced increased scrutiny from congressmembers Wednesday over the national shortage of its products. Anticipating more lawsuits and moving to coordinate them into multidistrict litigation before a single judge, plaintiffs’ lawyers considered selecting South Florida as the venue.
The attorneys discussed the cases at a Wednesday conference in Pittsburgh, as Abbott is facing lawsuits over its Michigan plant, which was shut down due to unsanitary conditions.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
